AMPH: Amphastar Pharmaceuticals Company Short-Term Debt

Symbol and logo of brand Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals (AMPH) possesses significant pricing power over scarce inhalers and injections, allowing for consistent price increases for clinics. This price chart helps track this process, where the current indicator is 0.07. The business relies on a team of top-tier chemical technologists who create complex drug formulations. Furthermore, the company's operations are fully insulated from economic cycles and seasonal demand fluctuations.

AMPH (Amphastar Pharmaceuticals Inc) Company Short-Term Debts history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company Amphastar Corp (AMPH)

- current quotes and average value forecast:
Price Chart Amphastar Pharmaceuticals, Inc.|AMPH - Fair Value Consensus
- market capitalization information:
Market Value Amphastar Pharmaceuticals, Inc.|AMPH - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Amphastar Pharmaceuticals|AMPH - Book Capitalization|Market Cap to Net Assets Ratio amphastar.com|AMPH - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Amphastar Pharmaceuticals|AMPH - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Amphastar Pharmaceuticals|AMPH - Company Cumulative Indebtedness|Debts to Book Capitalization Amphastar Pharmaceuticals, Inc.|AMPH - Company Long-Term Loans and Borrowings|Company Short-Term Debts Amphastar Pharmaceuticals|Quick Liquidity amphastar.com
- net income and valuation multiples indicators:
AMPH - Final Profit
Summary company analytics:Amphastar Pharmaceuticals, Inc. (AMPH)
Mass-produced product of amphastar.com

High FDA barriers and the complexity of producing inhalable generics at Amphastar Pharmaceuticals (AMPH) require a precise liquidity balance. An analysis of current borrowings allows for an assessment of obligations maturing within one year relative to working capital. This trend captures the efficiency of short-term debt management in maintaining margins. Rising debt may signal speculative risk or investments in R&D, while the stability of this metric confirms the business's financial resilience.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|PCRX: Company Short-Term Debts|ARS Pharmaceuticals Inc - Company Short-Term Loans and Borrowings|TBPH (Theravance) - Company Short-Term Debts|Short-Term Debt Aquestive Corp AQST|Company Short-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TNXP (Tonix Pharmaceuticals Holding Corp.)|Company Short-Term Debts SXT Pharmaceuticals SXTC|EPRX - Company Short-Term Debt|BioHarvest Sciences Inc (BHST) - Company Current Liabilities|eXoZymes Inc (EXOZ) - Company Short-Term Debt|Current Liabilities ORMP (Oramed Pharmaceuticals Inc.)|ENTX (Entera Bio Ltd) - Company Short-Term Debts|HYFT: Company Short-Term Loans and Borrowings|Company Short-Term Debts ABVC|Company Short-Term Debts Cumberland Corp (CPIX)|Company Short-Term Debt Quantum BioPharma Ltd QNTM|Short-Term Debt Volume fibrogen.com (FGEN)|TELO: Company Current Liabilities|Rani Therapeutics - Amount of Current Liabilities|SNYR: Company Short-Term Debts|Rallybio (RLYB) - Company Short-Term Debts|Company Short-Term Debt Lexaria Bioscience Corp|PULM: Company Short-Term Loans and Borrowings|Company Current Liabilities PTHL (Pheton Holdings Ltd)|APM (aptorumgroup.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Lyra Therapeutics, Inc LYRA|IBO (impactbiomedinc.com) - Current Liabilities|TNF Pharma - Company Short-Term Debts|Company Short-Term Loans and Borrowings YCBD (cbdMD, Inc.)|PRFX: Company Short-Term Debts|Altamira Therapeutics Ltd. (CYTO) - Company Short-Term Debts|Company Short-Term Debt Lipella|OPTN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|Company Current Liabilities procapsgroup.com PROC|Company Short-Term Debts PTPI (Petros Pharmaceuticals, Inc.)|Company Short-Term Debts Qilian International Holding Group QLI|ACELYRIN, Inc. - Company Short-Term Debts|TFF Pharmaceuticals, Inc (TFFP) - Company Current Liabilities